Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-l-phosphate

被引:131
作者
Siess, W [1 ]
机构
[1] Univ Munich, Fac Med, Inst Prevent Cardiovasc Dis, D-80336 Munich, Germany
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2002年 / 1582卷 / 1-3期
关键词
lysophosphatidic acid; sphingosine-1-phosphate; atherosclerosis; thrombosis; vascular tone; plaque stability; endothelial dysfunction; neointima; platelet activation;
D O I
10.1016/S1388-1981(02)00173-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lysophosphatidic acid (LPA) and sphingosine-1-phosphate (SIP) are potent bioactive phospholipids with specific and multiple effects on blood cells and cells of the vessel wall. Released by activated platelets, LPA and S1P mediate physiological wound healing processes such as vascular repair. Evidence is accumulating that these lipid mediators can, however, under certain conditions become athero- and thrombogenic molecules that might aggravate cardiovascular disease. For example, LPA present in minimally modified LDL and within the intima of atherosclerotic lesions may play a role in the early phase of atherosclerosis by inducing barrier dysfunction and increased monocyte adhesion of the endothelium, as well as in the late phase by triggering platelet activation and intra-arterial thrombus formation upon rupture of the atherosclerotic plaque. Moreover, LPA and S1P, by stimulating the proliferation of fibroblasts and by enhancing the survival of inflammatory cells are likely to play a central role in the excessive fibroproliferative and inflammatory response to vascular injury that characterizes the progression of atherosclerosis. Furthermore, LPA can cause the phenotypic dedifferentiation of medial vascular smooth muscle cells, and S1P is able to stimulate the migration and proliferation of intimal vascular smooth muscle cells; both processes ultimately lead to the formation of the neointima. Most importantly, as LPA and S1P bind to and activate multiple G-protein receptors, it emerges that the beneficial or harmful action of LPA and S1P are critically dependent on the expression profile of their receptor subtypes and their coupling to different signal transduction pathways in the target cells. By targeting specific subtypes of LPA and S1P receptors in selective cells of the vascular wall and blood, new strategies for the prevention and therapy of cardiovascular diseases can be envisioned. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:204 / 215
页数:12
相关论文
共 161 条
  • [1] Platelet-derived lysophosphatidic acid decreases endothelial permeability in vitro
    Alexander, JS
    Patton, WF
    Christman, BW
    Cuiper, LL
    Haselton, FR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (01): : H115 - H122
  • [2] AMERONGEN GPN, 2000, THROMB VASC BIOL, V20, pE127
  • [3] Transient and prolonged increase in endothelial permeability induced by histamine and thrombin -: Role of protein kinases, calcium, and RhoA
    Amerongen, GPV
    Draijer, R
    Vermeer, MA
    van Hinsbergh, VWM
    [J]. CIRCULATION RESEARCH, 1998, 83 (11) : 1115 - 1123
  • [4] Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase
    Augé, N
    Nikolova-Karakashian, M
    Carpentier, S
    Parthasarathy, S
    Négre-Salvayre, A
    Salvayre, R
    Merrill, AH
    Levade, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) : 21533 - 21538
  • [5] Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry
    Baker, DL
    Desiderio, DM
    Miller, DD
    Tolley, B
    Tigyi, GJ
    [J]. ANALYTICAL BIOCHEMISTRY, 2001, 292 (02) : 287 - 295
  • [6] Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species - Structure-activity relationship of cloned LPA receptors
    Bandoh, K
    Aoki, J
    Taira, A
    Tsujimoto, M
    Arai, H
    Inoue, K
    [J]. FEBS LETTERS, 2000, 478 (1-2) : 159 - 165
  • [7] Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets
    Bauer, M
    Retzer, M
    Wilde, JI
    Maschberger, P
    Essler, M
    Aepfelbacher, M
    Watson, SP
    Siess, W
    [J]. BLOOD, 1999, 94 (05) : 1665 - 1672
  • [8] Genetic and pharmacological analyses of involvement of Src-family, Syk and Btk tyrosine kinases in platelet shape change -: Src-kinases mediate integrin αIIbβ3 inside-out signaling during shape change
    Bauer, M
    Maschberger, P
    Quek, L
    Briddon, SJ
    Dash, D
    Weiss, M
    Watson, SP
    Siess, W
    [J]. THROMBOSIS AND HAEMOSTASIS, 2001, 85 (02) : 331 - 340
  • [9] BENTON AM, 1982, BLOOD, V60, P642
  • [10] ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS
    BERLINER, JA
    NAVAB, M
    FOGELMAN, AM
    FRANK, JS
    DEMER, LL
    EDWARDS, PA
    WATSON, AD
    LUSIS, AJ
    [J]. CIRCULATION, 1995, 91 (09) : 2488 - 2496